Abstract 1771
Background
Platelet activation and the release of various growth factors from platelet granules in response to tumor cell profoundly influence tumor biology. Platelet hyperreactivity in cancer patients is a frequently discussed phenomenon; however, cancer patients were also found to have platelet dysfunction. Considerably less is known about exhaustion of platelet kinetics in cancer.
Methods
In this study, we investigated kinetics of intra-platelet growth factors in hepatocellular carcinoma (HCC) recurrence. We prospectively recruited forty patients diagnosed with HCC who were undergoing liver resection. The patients were followed every three months with imagings after the resection. Platelet fractions were separately isolated before and after a month of radical resection of the tumor. Growth factors/cytokines were measured using enzyme-linked immunosorbent assay (ELISA) kits. Follow-up was standardized to two years. HCC recurrence was diagnosed on the basis of imaging.
Results
Fifteen patients developed post-resection HCC recurrence during 2-year follow-up. The concentrations of platelet-alpha granules secreted growth factors [vascular endothelial growth factor-A (VEGF-A), angiopoietin-1(Ang-1)] and dense granules secreted growth factors (serotonin) were significantly depleted in patients with early HCC recurrence. In addition, the post-resection platelet count was also significantly lower in patients with recurrence than those without recurrence. A combined receiver-operating characteristic (ROC) curve generated to determine the cut-off values for these growth factors yielded both specificity and sensitivity of greater than 80%, area under curve (AUC) > 0.8, and P < 0.001. Furthermore, in the binary logistic regression model, VEGF-A was able to independently predict early HCC recurrence (P < 0.05); accordingly, the disease-free interval was substantially worse in accordance with the exhausted intra-platelet growth factors.
Conclusions
We found a qualitative and quantitative platelet crisis, and its prognostic implication in patients with post-resection HCC recurrence. This study provides an avenue to identify the pathophysiological mechanism of the impaired platelet-kinetics and its relevance in cancer biology.
Clinical trial identification
Legal entity responsible for the study
Bibek Aryal.
Funding
Japan Society for the Promotion of Science (JSPS).
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1018 - Meta-enrichment analysis to identify a higher response patient population to S-1/Cisplatin for advanced gastric cancer
Presenter: Masahiro Takeuchi
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
1791 - Predictive significance of tumour angiogenic and anti-angiogenic VEGF-A splice variants in patients with metastatic colorectal cancer
Presenter: George Pentheroudakis
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
Slides
2063 - ATR inhibition with radiation creates an inflammatory tumour microenvironment.
Presenter: Magnus Dillon
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
2889 - RNA-based analysis of anaplastic lymphoma kinase (ALK) fusions in non-small cell lung cancer (NSCLC) cases showing immunohistochemistry/fluorescence in-situ hybridisation (IHC/FISH) discordance
Presenter: Claudia Vollbrecht
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4363 - The combination of MEK inhibitor and anti PD-L1: effects on organoid models from NSCLC biopsies
Presenter: Carminia Maria Della Corte
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
1467 - Intraoperative Fluorescent Image-Guided Detection of Esophageal Cancer in Rabbit and Patient Specimens
Presenter: Jiyun Rho
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
1522 - Interaction Between Cancer Associated Fibroblasts and Cancer Cells Influence Immune Infiltrate and Is Modulated by Therapeutic Agents
Presenter: Antonio Rullan Iriarte
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
3937 - Dynamic change of immune-related gene expression status during chemoradiotherapy in locally advanced esophageal cancer
Presenter: Takuro Mizukami
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5183 - CD5 and CD6: evaluation of their role as prognostic biomarkers in resectable non-small cell lung cancer
Presenter: Andrea Moreno
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5920 - Identification of the rational combination of two epigenetic inhibitors therapy in refractory AML using patient tumor derived ex vivo platform.
Presenter: Pradip Majumder
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract